Skip to main content
Eleonora Lad, MD, Ophthalmology, Durham, NC

EleonoraGLadMD

Ophthalmology • Durham, NC

Retinal Disease

Associate Professor of Ophthalmology, Duke University Medical Center

Join to view full profile

Dr. Lad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lad's full profile

Already have an account?

  • Office

    121 Crimson Oak Dr
    Durham, NC 27713
    Phone+1 650-796-8526
    Fax+1 919-660-5070

Education & Training

  • Duke University Medical Center
    Duke University Medical CenterFellowship, 2011 - 2012
  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityResidency, Ophthalmology, 2008 - 2011
  • Kaiser Permanente Northern California (Oakland)
    Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 2007 - 2008
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2007

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2008 - Present
  • NC State Medical License
    NC State Medical License 2011 - 2025
  • VA State Medical License
    VA State Medical License 2011 - 2012
  • American Board of Ophthalmology Ophthalmology
  • American Board of OphthalmologyBoard Certification

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Press Mentions

  • Photobiomodulation for Early Dry AMD Gets Enthusiastic Reception
    Photobiomodulation for Early Dry AMD Gets Enthusiastic ReceptionJuly 23rd, 2024
  • Apellis’ Syfovre Approved as First Treatment for Geographic Atrophy Despite Uncertain Clinical Benefit
    Apellis’ Syfovre Approved as First Treatment for Geographic Atrophy Despite Uncertain Clinical BenefitMarch 7th, 2023
  • New FDA-Approved Drug Can Slow Vision Loss for Those with Age-Related Eye Disease
    New FDA-Approved Drug Can Slow Vision Loss for Those with Age-Related Eye DiseaseFebruary 27th, 2023
  • Join now to see all

Dr. Eleonora Lad, Dr. Eleonora Lad, MD, Dr. E Lad, Dr. Eleonora G Lad